BamSEC and AlphaSense Join Forces
Learn More

Leap Therapeutics Inc.

NASDAQ: LPTX    
Share price (1/8/25): $3.38    
Market cap (1/8/25): $130 million

Material Contracts Filter

EX-10.2
from 10-Q 34 pages First Amended and Restated Collaboration Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Fourth Amendment to Lease
12/34/56
EX-10.1
from 8-K 34 pages Securities Purchase Agreement
12/34/56
EX-10.33
from 10-K 1 page Leap Therapeutics, Inc. Amendment No. 1 to the 2022 Equity Incentive Plan
12/34/56
EX-10.7
from 10-Q 3 pages First Amendment to Executive Employment Agreement
12/34/56
EX-10.6
from 10-Q 17 pages Executive Employment Agreement
12/34/56
EX-10.5
from 10-Q 3 pages Second Amendment to Executive Employment Agreement
12/34/56
EX-10.2
from 10-Q 38 pages Collaboration Agreement
12/34/56
EX-10.1
from 10-Q 57 pages Strategic Partnership and License Agreement
12/34/56
EX-10.1
from 8-K 3 pages Second Amendment to Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 5 pages Beigene, Ltd. C/O Mourant Ozannes Corporate Services (Cayman) Limited 94 Solaris Avenue Camana Bay Po Box 1348 Grand Cayman, Ky1-1108 Cayman Islands Attention: Chairman and Chief Executive Officer Re: Termination of Option and License; Continued Clinical Collaboration Ladies and Gentlemen,
12/34/56
EX-10.3
from 8-K 15 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 11 pages Support Agreement
12/34/56
EX-10.1
from 8-K 10 pages Support Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Third Amendment to Lease
12/34/56
EX-10.27
from 10-K 2 pages Second Amendment to Lease
12/34/56
EX-10.1
from 10-Q 2 pages First Amendment to Lease
12/34/56
EX-10.2
from 10-Q 3 pages First Amendment to Executive Employment Agreement
12/34/56
EX-10.1
from 10-Q 3 pages First Amendment to Executive Employment Agreement
12/34/56
EX-10.19
from 10-K 18 pages Executive Employment Agreement
12/34/56